Leukemia & Lymphoma
Volume 61, 2020 - Issue 3
Letters to the Editor
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma
, 
, , , , & show all
Faouzi DjebbariDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; http://orcid.org/0000-0001-9578-7632View further author information
http://orcid.org/0000-0001-9578-7632View further author information, , , , & Karthik RamasamyDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; ;NIHR Oxford Biomedical Research Centre Blood Theme, Oxford, UK; Correspondence[email protected]
http://orcid.org/0000-0003-3385-3707View further author information
http://orcid.org/0000-0003-3385-3707View further author information show all